Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- University of Antwerp
- University of Groningen
- Utrecht University
- ; University of Birmingham
- ; University of Cambridge
- Aalborg University
- AcademicTransfer
- Brno University of Technology, Central European Institute of Technology
- Chalmers University of Technology
- ETH Zurich
- Eindhoven University of Technology
- Institute of Biochemistry and Biophysics Polish Academy of Sciences
- Iowa State University
- RMIT University
- Radboud University Medical Center (Radboudumc)
- SciLifeLab
- Slovak University of Agriculture in Nitra
- The Netherlands Cancer Institute
- The University of Alabama
- University Medical Centre Groningen (UMCG)
- University of Central Florida
- Zuyd University
- 12 more »
- « less
-
Field
-
25 Apr 2024 Job Information Organisation/Company University Medical Centre Groningen (UMCG) Research Field Medical sciences Researcher Profile Recognised Researcher (R2) First Stage Researcher (R1
-
27 Apr 2024 Job Information Organisation/Company University of Antwerp Research Field Engineering » Biomedical engineering Engineering » Other Medical sciences » Other Physics » Other Researcher
-
The research group of Reuven Agami at the division of Oncogenomics at the Netherlands Cancer Institute in Amsterdam has recently uncovered a novel phenomenon in cancer termed “Sloppiness”. They showed that the tumor microenvironment enforces the production of aberrant proteins in cancer cells...
-
processing of MRI and light-sheet microscopy), biological and medical sciences (tissue microstructure, immunostaining, and neuroscience), and computer science (data analysis, machine learning, and artificial
-
25 Apr 2024 Job Information Organisation/Company Brno University of Technology, Central European Institute of Technology Research Field Chemistry Physics Researcher Profile First Stage Researcher
-
25 Apr 2024 Job Information Organisation/Company Radboud University Medical Center (Radboudumc) Research Field Medical sciences Physics Researcher Profile Recognised Researcher (R2) Country
-
-ESHPM, purchasers at EMC and UMCU, suppliers of medical devices and other consortium partners. The PhD candidate will be based in the Innovation, Technology Entrepreneurship & Marketing (ITEM) group at TU
-
cells, aiming to enhance treatment efficacy and contribute with new discoveries in cancer biology. Our models cover metabolism, signaling, and gene regulation, and we train them on extensive high
-
degree of Master of Science [Magister], Master of Engineering [Magister Inżynier], medical doctor or equivalent in the field of: exact sciences, natural sciences, medical sciences or related disciplines
-
chemistry, nucleic acid technology, and state-of-the-art biophysical methods (spectroscopy, live cell imaging and nanotechnology) to address cutting-edge questions in biology and meet medical challenges. Our